Associations between serum total bilirubin levels and functional dependence in the elderly

Internal Medicine Journal

Volumn 42, Issue 11, 2012, Pages 1199-1207

  Kao, T W ^a,b   Chou, C H ^c   Wang, C C ^a,b   Chou, C C ^a,b   Hu, J ^b   Chen, W L ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Elderly; Functional dependence; Serum total bilirubin

Indexed keywords

BILIRUBIN;

ADL DISABILITY; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL DEPENDENCE; FUNCTIONAL STATUS; GENERAL HEALTH QUESTIONNAIRE; HUMAN; INTERVIEW; LEISURE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF REPORT; SOCIAL BEHAVIOR;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BILIRUBIN; CROSS-SECTIONAL STUDIES; DIAGNOSTIC SELF EVALUATION; FEMALE; HABITS; HEALTH SURVEYS; HUMANS; HYPERBILIRUBINEMIA; INDEPENDENT LIVING; INFLAMMATION; MALE; MIDDLE AGED; MORBIDITY; MOTOR ACTIVITY; OXIDATION-REDUCTION; QUESTIONNAIRES; SOCIAL BEHAVIOR; UNITED STATES;

EID: 84869778708     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02620.x     Document Type: Article

References (30)

1. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V etal. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002; 160: 449-456.
2. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 2009; 106: 5171-5176.
3. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002; 99: 16093-16098.
4. Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1-57.
5. Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CH etal. Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun 2009; 386: 338-344.
6. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009; 40: 3422-3427.
7. Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 2001; 32: 580-583.
8. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198: 1-11.
9. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 18-23.
10. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC etal. Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 1996; 3: 459-463.
11. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 166-172.
12. Ioannou GN, Liou IW, Weiss NS. Serum bilirubin and colorectal cancer risk: a population-based cohort study. Aliment Pharmacol Ther 2006; 23: 1637-1642.
13. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008; 121: 781-788.
14. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ etal. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 639-646.
15. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G etal. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol 2004; 59: 242-248.
16. Kuo HK, Bean JF, Yen CJ, Leveille SG. Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J Gerontol 2006; 61: 380-387.
17. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB etal. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol 2002; 57: M326-332.
18. National Health and Nutrition Examination Survey (NHANES) 1999-2000. Bethesda, MD, National Center for Health Statistics, 2002 [cited 2008 Dec 12] Available from URL: http://www.cdc.gov/nchs/nhanes/currentnhanes.htm
19. National Health and Nutrition Examination Survey (NHANES) 2001-2002. Bethesda MD, National Center for Health Statistics, 2004 [cited 2008 Dec 12] Available from URL: http://www.cdc.gov/nchs/nhanes/current_nhanes_01_02.htm
20. Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, Sambrook PN etal. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol 2010; 65: 712-717.
21. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046.
22. Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, Chung HT. 3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 2006; 187: 274-284.
23. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
24. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-1216.
25. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S etal. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005; 112: 1030-1039.
26. Mietus-Snyder M, Friera A, Glass CK, Pitas RE. Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 1997; 17: 969-978.
27. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S etal. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004; 52: 1105-1113.
28. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol 2000; 55: M709-715.
29. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J etal. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002; 50: 1947-1954.
30. Masdeu JC, Wolfson L, Lantos G, Tobin JN, Grober E, Whipple R etal. Brain white-matter changes in the elderly prone to falling. Arch Neurol 1989; 46: 1292-1296.